Patient Experience Lab
Life sciences solutions require the blending of innovative science with brilliant experiences.
Helping biopharma companies connect with patients
The healthcare market is demanding a pivot toward an approach that leads with a focus on patient value. But only 30% of pharma companies are confident that they are able to deliver patient centricity and only 35% of patient groups report that they believe the industry is “excellent” or “good” at putting patients first.
Traditional approaches to drug design, development and commercialization are not well-positioned to deliver on the patient-centered needs of the industry. This is why we have introduced a new way to envision and deliver breakthrough care experiences and solutions, at scale.
With the Accenture Patient Experience Lab, we’ve created an end-to-end approach that combines experience, evidence and economics to drive human outcomes, at scale.
Looking at the human experience
The Accenture Patient Experience Lab was founded on five guiding principles:
- Shifting focus from clinical to human outcomes
- Leading with meaningful “missions”
- Unifying data science with the voice of the patient
- Embedding therapeutic depth into innovation
- Accelerating the “concept to scale” process
We work with pharma and biotechnology organizations from around the world, connecting them to the human experience. We help Define & Envision to generate new patient insights through data science and voice-of-the-patient perspectives; Co-Create & Validate to build relevant products and series and secure valuable patient feedback; and Enable & Scale to bring solutions to market and expand channels and audiences.
Learn more about the Patient Experience Lab through this SlideShare and hear directly from patients in these compelling videos.
SLIDESHARE
Patient Experience Lab slideshare
VIDEO
Patients share their healthcare experiences
VIDEO
A look at our biopharma patient summit
The evolving role of patient services
In a recent survey, we asked 4,000 patients about their experiences with patient services. We found they prefer to receive services from patient organizations over pharma companies.
54%
of patients said that they feel an emotional impact every day because of their condition. This rises to 72% for patients in the United States.
47%
of patients said that pharma companies understand their emotional, financial and other needs related to their condition.
64%
of patients are willing to share their health data with patient organizations to get better care.
What we think
Learn three steps biopharma marketers can take to drive growth.
Why pharma companies and patient organizations need to collaborate differently to deliver better patient experiences.
